VIO-01
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VIO-01, covering 2025-03-17 to 2025-03-17. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors [Phase 1, Phase 2]